
Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
Minimal Residual Disease: Tumor‑Informed vs Plasma‑Only
John explains MRD technologies, Signatera tumor‑informed validation, and prognostic power from Galaxy and Dynamic studies.
Play episode from 32:41
Transcript


